Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DB-020 in Healthy Volunteers

Trial Profile

Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DB-020 in Healthy Volunteers

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Nov 2018

At a glance

  • Drugs DB 020 (Primary) ; Hyaluronic acid
  • Indications Sensorineural hearing loss
  • Focus Adverse reactions
  • Sponsors Decibel Therapeutics
  • Most Recent Events

    • 01 Nov 2018 Planned initiation date changed from 18 Oct 2018 to 2 Nov 2018.
    • 24 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top